• Exchange: NASDAQ CM
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

Pluristem Therapeutics Inc

+ Add to Watchlist

PSTI:US

2.9090 USD 0.0610 2.05%

As of 11:32:38 ET on 10/22/2014.

Snapshot for Pluristem Therapeutics Inc (PSTI)

Open: 2.9600 Day's Range: 2.8900 - 2.9600 Volume: 36,790
Previous Close: 2.9700 52wk Range: 2.5800 - 4.6300 1-Yr Rtn: -21.38%

Stock Chart for PSTI

No chart data available.
  • PSTI:US 2.9090
  • 1D
  • 1M
  • 1Y
2.9700
Interactive PSTI Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for PSTI

Current P/E Ratio (ttm) -
Estimated P/E(06/2015) -
Relative P/E vs. SPX -
Earnings Per Share (USD) (ttm) -0.4200
Est. EPS (USD) (06/2015) -0.4570
Est. PEG Ratio -
Market Cap (M USD) 205.76
Shares Outstanding (M) 69.28
30 Day Average Volume 181,548
Price/Book (mrq) 3.2124
Price/Sale (ttm) 480.6919
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 11/05/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for PSTI

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for PSTI

Pluristem Therapeutics, Inc. develops Messenchymal stem cell production technology and commercializes cell therapy products. The Company focuses on cell therapy to treat severe blood, cardiovascular, autoimmune, and other disorders.

Zami AbermanChief Executive OfficerYaky YanayPresident/COO
Boaz Gur-LavieCFO/Secretary
More Company Profile & Key Executives for PSTI

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil